How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
Piercarlo Sarzi‐Puttini, Daniela Marotto, M. Antivalle, Fausto Salaffi, Fabiola Atzeni, Giovanni Maconi, Giovanni Monteleone, Giuliano Rizzardini, Spinello Antinori, Massimo Galli, Sandro Ardizzone
Topics & Concepts
MedicineIntensive care medicineCoronavirus disease 2019 (COVID-19)Economic shortageRisk stratificationExpert opinionInflammatory Bowel DiseasesRheumatologyClinical trialImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInflammatory bowel diseaseInternal medicineOutbreakPathologyDiseaseInfectious disease (medical specialty)Government (linguistics)PhilosophyLinguisticsCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesInflammatory Bowel Disease